|
Re: Esperion
|
2
|
Resverlogix Corp.
|
Mar 20, 2017 12:01PM
|
|
Re: March Madness
|
2
|
Resverlogix Corp.
|
Mar 20, 2017 01:01PM
|
|
IND filing for Renal Trial
|
4
|
Resverlogix Corp.
|
Mar 20, 2017 04:41PM
|
|
Re: IND filing for Renal Trial
|
1
|
Resverlogix Corp.
|
Mar 20, 2017 10:42PM
|
|
Re: IND filing for Renal Trial
|
2
|
Resverlogix Corp.
|
Mar 21, 2017 06:26AM
|
|
Re: New presentation
|
2
|
Resverlogix Corp.
|
Mar 21, 2017 11:50AM
|
|
Re: New presentation
|
2
|
Resverlogix Corp.
|
Mar 21, 2017 01:45PM
|
|
BETonMACE Enrollment
|
7
|
Resverlogix Corp.
|
Mar 21, 2017 04:22PM
|
|
biOasis Announces Non-Brokered Private Placement
|
|
BIOASIS TECHNOLOGIES INC
|
Mar 21, 2017 09:56PM
|
|
Re: BETonMACE Enrollment
|
7
|
Resverlogix Corp.
|
Mar 24, 2017 03:15PM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Mar 24, 2017 03:34PM
|
|
Re: BETonMACE Enrollment
|
4
|
Resverlogix Corp.
|
Mar 25, 2017 11:14AM
|
|
Re: BETonMACE Enrollment
|
5
|
Resverlogix Corp.
|
Mar 25, 2017 04:07PM
|
|
Re: BETonMACE Enrollment
|
6
|
Resverlogix Corp.
|
Mar 26, 2017 03:01PM
|
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
2
|
Zenith Epigenetics
|
Mar 27, 2017 11:38AM
|
|
Re: RVX, protein, inflammation and MS
|
5
|
Resverlogix Corp.
|
Mar 27, 2017 02:01PM
|
|
Zacks SCR Report 3/27/2017
|
7
|
Resverlogix Corp.
|
Mar 27, 2017 06:10PM
|
|
Re: RVX, protein, inflammation and MS
|
4
|
Resverlogix Corp.
|
Mar 28, 2017 11:05AM
|
|
BiOasis presenting at Brains for Brain 2017 meeting
|
|
BIOASIS TECHNOLOGIES INC
|
Mar 28, 2017 11:43AM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Mar 28, 2017 03:26PM
|
